Title |
Radiological complete remission in HER2-positive metastatic breast cancer patients: what to do with trastuzumab?
|
---|---|
Published in |
Breast Cancer Research and Treatment, September 2019
|
DOI | 10.1007/s10549-019-05427-1 |
Pubmed ID | |
Authors |
T. G. Steenbruggen, N. I. Bouwer, C. H. Smorenburg, H. N. Rier, A. Jager, K. Beelen, A. J. ten Tije, P. C. de Jong, J. C. Drooger, C. Holterhues, J. J. E. M. Kitzen, M. -D. Levin, G. S. Sonke |
X Demographics
The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Brazil | 4 | 44% |
Japan | 1 | 11% |
Brunei Darussalam | 1 | 11% |
Croatia | 1 | 11% |
Unknown | 2 | 22% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 4 | 44% |
Scientists | 3 | 33% |
Members of the public | 2 | 22% |
Mendeley readers
The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 36 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 7 | 19% |
Other | 5 | 14% |
Student > Ph. D. Student | 5 | 14% |
Student > Bachelor | 2 | 6% |
Student > Postgraduate | 2 | 6% |
Other | 3 | 8% |
Unknown | 12 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 9 | 25% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 14% |
Economics, Econometrics and Finance | 4 | 11% |
Agricultural and Biological Sciences | 2 | 6% |
Business, Management and Accounting | 1 | 3% |
Other | 1 | 3% |
Unknown | 14 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 September 2019.
All research outputs
#5,843,776
of 23,511,526 outputs
Outputs from Breast Cancer Research and Treatment
#1,286
of 4,732 outputs
Outputs of similar age
#101,104
of 341,754 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#14
of 74 outputs
Altmetric has tracked 23,511,526 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,732 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 341,754 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 74 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.